Anpac Bio-Medical Science Co. buy me8
Start price
14.12.20
/
50%
€106.00
Target price
14.12.21
€240.00
Performance (%)
-15.09%
End price
29.01.21
€90.00
Summary
This prediction ended on 29.01.21 with a price of €90.00. The price of Anpac Bio-Medical Science Co. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -15.09%. me8 has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Anpac Bio-Medical Science Co. | -5.687% | -5.687% | -91.844% | -99.479% |
iShares Core DAX® | 4.015% | 2.971% | 16.492% | 19.144% |
iShares Nasdaq 100 | 2.755% | 0.503% | 40.029% | 50.636% |
iShares Nikkei 225® | -0.826% | -5.057% | 14.566% | 2.379% |
iShares S&P 500 | 2.330% | 0.720% | 30.194% | 44.181% |
According to me8 what are the pros and cons of Anpac Bio-Medical Science Co. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Good culture
Future proof or reliable business model
Cons
Growths slower than the competition
Dependend from some customers or products
Comments by me8 for this prediction
In the thread AnPac Bio-Medical Science Co. Ltd. ADR diskutieren
Buy mit Kursziel 12,0
In the thread Trading AnPac Bio-Medical Science Co. Ltd. ADR
Buy beendet